Benzazepine compound
US8940727B2 · kind B2 · utility
1Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2010 |
| Grant date | Jan 27, 2015 |
| Priority date | — |
| Expiry date | Oct 25, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object of the present invention is to provide a novel benzazepine compound or a salt thereof, which has excellent vasopressin antagonistic activity.The benzazepine compound or a salt thereof of the present invention is represented by Formula (1):wherein R1, R2 and R5 may be the same or different and each represents H or D; and R3 and R4 each represents a C1-6 alkyl group, a C1-6 deuteroalkyl group, or a C1-6 perdeuteroalkyl group.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.